PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Ranolazine - Angina

PAD Profile : Ranolazine - Angina

Brand Names Include :
Ranexa

Traffic Light Status

Status 1 of 1.

Status :
Amber
Important
Formulations :
  • Modified release tablets
Important Information :
Restricted to cardiology
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

No indications returned.

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
01 February 2017
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
A scheduled review of the expired Amber Shared Care document has taken place and was approved at PCN. The place in therapy of Ranolazine for stable Angina had previously been discussed by the PCN in March 2012 and the policy statement from those discussions still stands. See below for approved AMBER Shared Care and policy statement (PCN 13-2012) from previous discussions.

Associated BNF Codes

02. Cardiovascular System
02.06.03. Other antianginal drugs
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More